Mostrar el registro sencillo del ítem

dc.contributor.authorBraulio, Gilbertopt_BR
dc.contributor.authorPassos, Sávio Cavalcantept_BR
dc.contributor.authorLeite, Fabrício Mourapt_BR
dc.contributor.authorSchwertner, Andrépt_BR
dc.contributor.authorStefani, Luciana Paula Cadorept_BR
dc.contributor.authorSouza, Ana Cláudia dept_BR
dc.contributor.authorTorres, Iraci Lucena da Silvapt_BR
dc.contributor.authorFregni, Felipept_BR
dc.contributor.authorCaumo, Wolneipt_BR
dc.date.accessioned2018-04-05T02:26:11Zpt_BR
dc.date.issued2018pt_BR
dc.identifier.issn1663-9812pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/174454pt_BR
dc.description.abstractBackground: Remifentanil-induced hyperalgesia (r-IH) involves an imbalance in the inhibitory and excitatory systems. As the transcranial Direct Current Stimulation (tDCS) modulates the thalamocortical synapses in a top-down manner, we hypothesized that the active (a)-t-DCS would be more effective than sham(s)-tDCS to prevent r-IH. We used an experimental paradigm to induce temporal summation of pain utilizing a repetitive cold test (rCOLDT) assessed by the Numerical Pain Score (NPS 0-10) and we evaluated the function of the descending pain modulatory system (DPMS) by the change on the NPS (0–10) during the conditioned pain modulation (CPM)-task (primary outcomes). We tested whether a-tDCS would be more effective than s-tDCS to improve pain perception assessed by the heat pain threshold (HPT) and the reaction time during the ice-water pain test (IPT) (secondary outcomes). Methods: This double-blinded, factorial randomized trial included 48 healthy males, ages ranging 19–40 years. They were randomized into four equal groups: a-tDCS/saline, s-tDCS/saline, a-tDCS/remifentanil and s-tDCS/remifentanil. tDCS was applied over the primary motor cortex, during 20 min at 2 mA, which was introduced 10 min after starting remifentanil infusion at 0.06 mg kg􀀀1 min􀀀1 or saline Results: An ANCOVA mixed model revealed that during the rCOLDT, there was a significant main effect on the NPS scores (F = 3.81; P = 0.01). The s-tDCS/remifentanil group presented larger pain scores during rCOLDT, [mean (SD) 5.49 (1.04)] and a-tDCS/remifentanil group had relative lower pain scores [4.15 (1.62)]; showing its blocking effect on r-IH. a-tDCS/saline and s-tDCS/saline groups showed lowest pain scores during rCOLDT, [3.11 (1.2)] and [3.15 (1.62)], respectively. The effect of sedation induced by remifentanil during the rCOLDT was not significant (F = 0.76; P = 0.38). Remifentanil groups showed positive scores in the NPS (0–10) during the CPM-task, that is, it produced a disengagement of the DPMS. Also, s-tDCS/Remifentanil compared to a-tDCS showed lower HPT and larger reaction-time during the IPT. Conclusion: These findings suggest that effects of a-tDCS prevent the summation response induced by r-IH during rCOLDT and the a-tDCS blocked the disengagement of DPMS. Thereby, tDCS could be considered as a new approach to contra-regulate paradoxical mechanisms involved in the r-IH. Clinical trials identification: NCT02432677. URL:https://clinicaltrials.gov/.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofFrontiers in Pharmacology. Lausanne. Vol. 9, no. 9 (Feb. 2018), article 94 p. 1-11pt_BR
dc.rightsOpen Accessen
dc.subjecttDCSen
dc.subjectHiperalgesiapt_BR
dc.subjectEstimulação transcraniana por corrente contínuapt_BR
dc.subjectRemifentanilen
dc.subjectHyperalgesiaen
dc.subjectPain thresholden
dc.subjectCPMen
dc.titleEffects of transcranial direct current stimulation block remifentanil-induced hyperalgesia : a randomized, double-blind clinical trialpt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001063175pt_BR
dc.type.originEstrangeiropt_BR


Ficheros en el ítem

Thumbnail
   

Este ítem está licenciado en la Creative Commons License

Mostrar el registro sencillo del ítem